Target intelligence / Profile preview

Lysine-specific demethylase 4B (KDM4B) (KDM4B)

Target
KDM4B
Molecular classification
Enzyme, Histone modification
01

Overview

Lysine-specific demethylase 4B (KDM4B), also known as JMJD2B, is a member of the Jumonji C (JmjC) domain-containing family of histone demethylases. It specifically catalyzes the demethylation of di- and tri-methylated lysine 9 on histone H3 (H3K9me2/me3), thereby acting as a critical epigenetic regulator that relaxes chromatin structure to facilitate gene transcription, DNA replication, and DNA repair. KDM4B is frequently overexpressed in various malignancies, including breast, prostate, colorectal, and gastric cancers, as well as pediatric rhabdomyosarcoma and atypical teratoid/rhabdoid tumors (ATRT). In these contexts, it functions as an oncogene by co-activating key transcription factors like the estrogen receptor (ER), androgen receptor (AR), and the PAX3-FOXO1 fusion protein, thereby promoting cell proliferation, survival, and metastasis.

Beyond oncology, KDM4B has been implicated in driving host inflammatory responses and osteoclastogenesis in periodontal disease. Consequently, KDM4B is a highly attractive therapeutic target. Small-molecule inhibitors, such as the clinical-stage pan-KDM4 inhibitor zavondemstat (TACH101) and preclinical compounds like QC6352 and ML324, target KDM4B by competing with its co-factor alpha-ketoglutarate or chelating the catalytic Fe(II) ion in its active site. However, recent studies have revealed that some of these inhibitors, including zavondemstat and QC6352, also potently inhibit dihydroorotate dehydrogenase (DHODH), suggesting that their therapeutic efficacy and safety profiles may involve dual epigenetic and metabolic mechanisms.

Other names
Jumonji domain-containing protein 2BJmjC domain-containing histone demethylation protein 3BJHDM3BJMJD2BKIAA0876TDRD14B[histone H3]-trimethyl-L-lysine(9) demethylase 4B
02

Mechanism of action

Inhibition of the demethylase activity of KDM4B by competing with the co-factor alpha-ketoglutarate (2-oxoglutarate) and/or chelating the catalytic Fe(II) ion in the JmjC active site, thereby preventing the demethylation of histone H3 lysine 9 (H3K9me3/me2).

03

Biological functions

Cell cycleCell proliferationApoptosisImmune responseOther
04

Disease associations

CancerInflammationOther
05

Safety considerations

Off-target toxicity due to lack of selectivity among JmjC domain-containing demethylasesPotential dose-limiting toxicities (e.g., gastrointestinal issues like diarrhea, fatigue, nausea, hyponatremia)Functional redundancy among KDM4 isoforms requiring pan-inhibitionPotential off-target effects on other iron- and 2-oxoglutarate-dependent dioxygenasesRecent findings showing dual inhibition of DHODH by some KDM4 inhibitors (e.g., QC6352, zavondemstat) which may lead to pyrimidine depletion and associated toxicities
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

H3K9me3 levelsH3K36me3 levelsAndrogen receptor (AR) expressionEstrogen receptor (ER) expressionPAX3-FOXO1 fusion status

Beyond the preview

Go deeper on Lysine-specific demethylase 4B (KDM4B) (KDM4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine-specific demethylase 4B (KDM4B) (KDM4B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call